PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Biophytis SA, Sorbonne Université - BC9, 4 place Jussieu, 75005, Paris, France.\', \'Biophytis, Inc, 210 Broadway, Suite #201, Cambridge, MA, 02139, USA.\', \'Service de Pneumologie, Médecine Intensive et Réanimation - R3S (SPMIR-R3S), Hôpital Pitié-Salpêtrière - APHP, Paris, France.\', \'Universidade de São Paulo Instituto do Coração, São Paulo, SP, Brasil.\', \'General Hospital Sint-Maarten, Mechelen, Belgium.\', \'Oakland University William Beaumont School of Medicine, Royal Oak, MI, USA.\', \'Queen Elizabeth Hospital Birmingham, Birmingham, B15 2GW, UK.\', \'Sorbonne Université, CNRS - Institut de Biologie Paris Seine (B2A), 75005, Paris, France.\', \'Sorbonne Université, CNRS - Institut de Biologie Paris Seine (BIOSIPE), 75005, Paris, France.\', \'Biophytis, Inc, 210 Broadway, Suite #201, Cambridge, MA, 02139, USA. sam.agus@biophytis.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s13063-020-04998-5
?:doi
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 33430924
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33430924>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33430924>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all